Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2023-12-11 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
会计师事务所选聘制度（2023年12月）
Governance Information Classification · 95% confidence The document is titled '健帆生物科技集团股份有限公司 会计师事务所选聘制度' which translates to 'JH Biotech Group Co., Ltd. Auditor Selection System'. It details the procedures, requirements, and governance related to the selection, appointment, and replacement of the company's accounting firm (auditor). It references relevant laws and regulations, outlines the roles of the audit committee, board, and shareholders in the selection process, and describes supervisory and disciplinary measures. The document is a policy or governance document about auditor selection rather than an audit report, annual report, or financial statement. It does not contain financial data or audit results but focuses on governance and procedural rules. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-12-11 Chinese
关于部分募投项目结项并将节余募集资金永久补充流动资金的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the completion of certain fundraising investment projects and the permanent allocation of surplus raised funds to working capital. It details the use and management of funds raised through convertible bonds, the approval process by the board and supervisory committees, and the need for shareholder approval. The document includes references to regulatory guidelines on fundraising and fund management, but it does not contain financial statements or detailed financial performance data. It is primarily an announcement about the use of raised capital and related approvals, not a full financial report or audit. The document length is 4532 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under the category of Capital/Financing Update (CAP), as it updates on the use and management of fundraising proceeds and capital structure changes.
2023-12-11 Chinese
关于召开2023年第二次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about convening the 2023 second extraordinary general meeting of shareholders for a company, including meeting time, location, agenda items, voting procedures, and proxy forms. It contains no financial statements or results but focuses on the meeting logistics and proposals to be voted on. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or other shareholder meetings. The document is not an announcement of voting results, nor a report of financial performance or management changes. Therefore, the classification is AGM Information (AGM-R).
2023-12-11 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, compliance with regulatory guidelines, and the timeline of the repurchase activity. It does not contain financial statements or earnings data but focuses on the company's buyback activity. The document length is short (1534 characters) and is a formal announcement of share repurchase progress, fitting the category of Transaction in Own Shares (POS).
2023-12-04 Chinese
关于全资子公司取得新产品医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining a new medical device registration certificate. It details the product, registration specifics, and potential impact on the company. There is no financial data, no mention of financial results, no regulatory certifications or attestations, and no indication of a report being attached or published. The content is an operational update about product certification, which does not fit into financial reports, management changes, or governance documents. It is a regulatory announcement about a product certification, which best fits under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2023-11-13 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the progress of the company's share repurchase plan, detailing the number of shares repurchased, prices, compliance with regulatory guidelines, and future intentions. It does not contain financial statements or detailed financial analysis but focuses on the company's buyback activities. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's repurchase of its own shares.
2023-11-02 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.